Clinical Trials Browser

Phase 1/2 × NETWORK × pepinemab × Clear all

NCT03320330 2024-07-15

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Phase 1/2 Completed

26 enrolled 20 charts

Osteosarcoma